当前位置: X-MOL首页最新SCI期刊查询及投稿分析系统 › EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY杂志
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
基本信息
期刊名称 EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
EUR J CLIN PHARMACOL
期刊ISSN 0031-6970
期刊官方网站 http://www.springer.com/biomed/pharmaceutical+science/journal/228
是否OA
出版商 Springer Verlag
出版周期 Monthly
始发年份 1970
年文章数 169
最新影响因子 2.4(2023)  scijournal影响因子  greensci影响因子
中科院SCI期刊分区
大类学科 小类学科 Top 综述
医学3区 PHARMACOLOGY & PHARMACY 药学3区
CiteScore
CiteScore排名 CiteScore SJR SNIP
学科 排名 百分位 2.71 1.044 1.225
Medicine
Pharmacology (medical)
67 / 232 71%
Pharmacology, Toxicology and Pharmaceutics
Pharmacology
102 / 300 66%
补充信息
自引率 4.80%
H-index 92
SCI收录状况 Science Citation Index
Science Citation Index Expanded
官方审稿时间
网友分享审稿时间 数据统计中,敬请期待。
PubMed Central (PMC) http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0031-6970%5BISSN%5D
投稿指南
期刊投稿网址 https://mc.manuscriptcentral.com/ejcp?PROXY_TO_PAGE_NAME=&PRE_ACTION=&DISPLAY=&CURRENT_PAGE=LOGIN&SAVE_MS_DETAILS_VALIDATE_FL=&SAVE_MS_DETAILS_FL=&NEX
收稿范围

The European Journal of Clinical Pharmacology publishes original papers on all aspects of clinical pharmacology and drug therapy in humans. Manuscripts are welcomed on the following topics: therapeutic trials, pharmacokinetics/pharmacodynamics, pharmacogenetics, drug metabolism, adverse drug reactions, drug interactions, all aspects of drug development, development relating to teaching in clinical pharmacology, pharmacoepidemiology, and matters relating to the rational prescribing and safe use of drugs. Methodological contributions relevant to these topics are also welcomed.

Data from animal experiments are accepted only in the context of original data in man reported in the same paper. EJCP will only consider manuscripts describing the frequency of allelic variants in different populations if this information is linked to functional data or new interesting variants. Highly relevant differences in frequency with a major impact in drug therapy for the respective population may be submitted as a letter to the editor.

    Straightforward phase I pharmacokinetic or pharmacodynamic studies as parts of new drug development will only be considered for publication if the paper involves

    • a compound that is interesting and new in some basic or fundamental way, or
    • methods that are original in some basic sense, or
    • a highly unexpected outcome, or
    • conclusions that are scientifically novel in some basic or fundamental sense.

      Straightforward descriptive data in drug utilization will only be considered if more than one geographical area is studied and if a scientific hypothesis is tested or an intervention carried out. Descriptive data in drug utilization can however be quite useful in a more local setting. Again, if conceptually new methods, analysis, or ways of reasoning are involved, this would elicit greater interest from the international scientific community. In such a case, we would welcome submission to the EJCP and evaluate the paper according to standard procedures.

      The Journal also accepts review articles on various topics related to drug action in man. Debate on controversial issues is also encouraged, usually in the form of a letter to the editor that comments on a paper published in the Journal. Case reports on new findings or a new understanding of a mechanism of action should usually also be submitted in the form of a letter to the editor.


      收录体裁
      投稿指南
      投稿模板
      参考文献格式
      编辑信息

      Coordinating Editor

      Rune Dahlqvist
      Division of Clinical Pharmacology
      University Hospital
      90185 Umeå
      Sweden

      E-mail: Rune.Dahlqvist@pharm.umu.se

      Managing Editors 
      Uwe Fuhr, Cologne
      Emilio J. Sanz, La Laguna
      David J.P. Williams, Dublin
      Markus Zeitlinger, Vienna

      Reviews Editor
      Uwe Fuhr, Cologne

      Advisory Editors
      Karel Allegaert, Leuven 
      Janne Backman, Helsinki 
      Julio R. Benítez, Badajoz
      Joseph S. Bertino Jr, Albany
      Maurizio Bonati, Milan
      Ylva Böttiger, Huddinge
      Alasdair M. Breckenridge, Liverpool
      Ingolf Cascorbi, Kiel
      Imtiaz Choonara, Derby
      Balram Chowbay, Singapore
      Fan K. Chung, London
      Uwe Christians, Denver
      Marja-Liisa Dahl, Stockholm

      Rafael Dal-Ré, Madrid
      Vita Dolzan, Ljubljana
      Johan Fastbom, Stockholm
      Robin E. Ferner, Birmingham
      Alberg Figueras, Barcelona
      Sarah Foley, Cork
      Sebstian Frechen, Köln
      Takahisa Furuta, Hamamatsu
      Andrea Gaedigk, Kansas City
      Silvio Garattini, Milan
      Walter E. Haefeli, Heidelberg
      Staffan Hägg, Linköping
      Job Harenberg, Mannheim
      Martin Hellmich, Köln
      Georg Hempel, Münster
      Martin Henriksson, Linköping
      Christoph Hiemke, Mainz
      Nick Holford, Auckland
      Kalle Hoppu, Helsinki
      Alexander Jetter, Zurich
      Frieder Keller, Ulm
      Stephan Krähenbühl, Basel
      Joan R. Laporte, Barcelona
      Andreas Lindauer, Oss
      Jörn Lötsch, Frankfurt
      Arduino A. Mangoni, Bedford Park
      Patricia McGettigan, London
      Juan Merlo, Malmö 
      John Miners, Adelaide
      Klaus Mörike, Tübingen
      Nicola Montanaro, Bologna
      Jean-Louis Montastruc, Toulouse
      Nicholas Moore, Bordeaux
      Domenico Motola, Bologna
      Pertti J. Neuvonen, Helsinki
      Hedvig M.E. Nordeng, Oslo
      Stefan Oswald, Greifswald
      Roberto Raschetti, Roma
      Christoph Ritter, Greifswald
      Cristín Ryan, Dublin
      Laura J. Sahm, Cork
      Jörn Schneede, Umeå
      Folke Sjöqvist, Huddinge
      Olav Spigset, Trondheim
      Edoardo Spina, Messina
      Julia C. Stingl, Bonn
      John Stinson, Crumblin
      J.J. Swen, Leiden
      Petra Thürmann, Wuppertal
      Dietmar Trenk, Bad Krozingen
      Ellen Vinge, Lund
      Susanna M. Wallerstedt, Gothenburg
      Tom Walley, Liverpool
      Matthew Walters, Glasgow
      William S. Waring, York
      Martin Wehling, Mannheim
      Björn Wettermark, Stockholm
      Nick J. White, Oxford
      Ken W. Woodhouse, Cardiff
      Ümit Yasar, Ankara
      Hong-Hao Zhou, Changsha


      我要分享  (欢迎您来完善期刊的资料,分享您的实际投稿经验)
      研究领域:
      投稿录用情况: 审稿时间:  个月返回审稿结果
      本次投稿点评:
      提交
      down
      wechat
      bug